McEwen Mining (NYSE: MUX) (TSX: MUX) was featured in a recent article that discussed the transformation of a nearly 150-year old Japanese firm into the country’s hottest stock amid burgeoning growth in the AI sector. “The current boom in AI has turned a previously little-known Japanese company into a star on the stock market. Fujikura, which…
Thumzup (NASDAQ: TZUP) is at the forefront of modernizing the marketing industry with its unique platform designed to connect advertisers directly with everyday social media users. “The company’s mission is to empower individuals by turning their authentic social media activity into a monetizable asset while providing brands with cost-effective and impactful advertising solutions,” reads a recent…
Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases, such as Alzheimer’s (“AD”) and Parkinson’s (“PD”). The company concluded the third quarter with the completion of significant milestones and a clear path forward for its lead candidate, buntanetap. “Buntanetap is an innovative drug designed to target neurodegeneration by…
HeartBeam (NASDAQ: BEAT) has received FDA 510(k) clearance for its groundbreaking HeartBeam system, a credit card-sized, cable-free ECG device designed for comprehensive arrhythmia assessment. The system enables patients to record high-fidelity heart signals from three directions during symptoms, with data transmitted to physicians for timely review and action. This milestone marks the first FDA-cleared device…
SolarBank (NASDAQ: SUUN) (CSE: SUNN) (NEO: SUNN) (FSE: GY2), an independent renewable and clean energy project developer and owner focusing on distributed and community solar projects in Canada and the U.S., has announced the results of its 2024 annual general and special meeting of shareholders. The nominees listed in the management information circular for the…
McEwen Mining (NYSE: MUX) (TSX: MUX) is poised to benefit amid the growing use of artificial intelligence (“AI”) in everyday life activities. As the use of AI tools trends upward, such as in the job application process among countless others, “The companies behind those AI tools could be basking in the limelight of their innovations, but…
Thumzup (NASDAQ: TZUP), has officially integrated its platform with Elon Musk’s X Corp (formerly Twitter), granting advertisers access to X’s 535 million monthly active users. This integration empowers Thumzup to deliver real-time, locally targeted campaigns that connect brands with users who authentically promote their products. CEO Robert Steele highlighted the partnership as a transformative step…
NextPlat (NASDAQ: NXPL, NXPLW) announced that its U.S.-based connectivity division, Outfitter Satellite Inc., has been awarded a three-year contract by a U.S. state government to provide satellite connectivity services. The agreement includes satellite airtime service plans and hardware to support the government workforce during remote operations and natural disasters, with an option to extend for two…
Mullen Automotive (NASDAQ: MULN) announced that its subsidiary, Bollinger Motors, has partnered with St. Louis-based Broadway Ford Truck Center as an official dealer, enhancing its Midwest presence. Bollinger’s all-electric Class 4 commercial truck, the B4 Chassis Cab, which features a 158-kilowatt-hour battery and fleet-focused design, began deliveries in October. Broadway Ford Truck Center’s President, Dennis…
D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing, announced that CEO Dr. Alan Baratz recently appeared on Fox Business’ Making Money with Charles Payne, discussing the state of the quantum industry and D-Wave’s advancements in the space. Dr. Baratz emphasized that D-Wave operates the world’s largest quantum computers, which are being used now…
CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company developing treatments for brain and central nervous system cancers, will host a Virtual Analyst & Investor Day on December 11 from 11:30 a.m. to 1 p.m. ET. The event will feature presentations by the company’s leadership team, including CEO John Climaco, Chief Medical Officer Dr. Sandra Silberman, and…
Annovis Bio (NYSE: ANVS), a leader in developing treatments for neurodegenerative diseases, was recently featured on Today’s Marketplace in an exclusive interview with Dr. Maria Maccecchini, Founder, President, and CEO. Dr. Maccecchini detailed Annovis Bio’s groundbreaking drug development targeting toxic proteins responsible for nerve cell damage in Alzheimer’s and Parkinson’s, as well as the company’s…
Thumzup Media Corp. (NASDAQ: TZUP) plans to integrate its innovative ad tech platform with X Corp. (formerly Twitter), expanding its reach to over 535 million monthly active users. This integration, expected by January 2025, complements Thumzup’s existing presence on Instagram, allowing unified campaign management, enhanced audience targeting, and user monetization through authentic brand endorsements. CEO…
McEwen Mining (NYSE: MUX) (TSX: MUX) is positioned for opportunity as artificial intelligence is rapidly reshaping the landscape of economies around the world. “Estimates indicate that generative AI alone will triple its growth to a total market value of $1.3 trillion in the next decade… As most investors know by now, there is a surge…
Annovis Bio (NYSE: ANVS), a clinical-stage company developing therapies for neurodegenerative diseases, will host a live investor webcast on Dec. 11, 2024, at 4:30 PM EST. Led by Founder and CEO Dr. Maria Maccecchini, the event will highlight updates on Phase 3 studies for Parkinson’s and Alzheimer’s diseases, regulatory milestones, financial strategies, and plans for…
SuperCom (NASDAQ: SPCB) reported a solid performance for Q3 2024, with year-to-date revenue reaching $21.3 million, a 2% increase over the prior year, and gross profit rising 35% to $10.7 million. Strategic contract wins, including a 5-year electronic monitoring project with Israel Prison Service and multiple U.S. contracts in states like West Virginia, Maryland, and New…
Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on developing innovative biological products targeting inflammation and immunology (“I&I”) and offering contract development and manufacturing organization (“CDMO”) services through its Scinai Bioservices division, released its financial results for the nine months ending Sept. 30, 2024. The announcement highlights the company’s progress in advancing its I&I-focused pipeline…
Mullen Automotive (NASDAQ: MULN), an electric vehicle manufacturer, provided an update on its Fullerton, California, battery operations, which focus on producing next-generation battery packs and modules domestically. This initiative supports Mullen’s commitment to zero emissions and reducing reliance on imported battery components. CEO and Chairman David Michery emphasized the company’s mission to transition to American-made…